Jets and Lupus Research Alliance to Host Lupus Awareness Day on Sunday Story October 26, 2022 The New York Jets and Lupus Research Alliance will host Lupus Awareness Day on October 30, 2022,...
From Struggling to Walk to Running NYC TCS Marathon! Story October 18, 2022 Ten years ago, Megan Rosa struggled to walk because of her lupus – now she’s training for...
Lupkynis® (voclosporin) Granted Marketing Authorization in the European Union for Lupus Nephritis News Update September 22, 2022 September 21, 2022 Lupkynis® (voclosporin) was just granted marketing authorization in the European Union as a new treatment for adults...
CAR T Cell Therapy Induces Lupus Remission in Small Study News Update September 21, 2022 Results of a small study published in the prestigious journal Nature Medicine, suggest that a type of immune...
2022 Breaking Through Gala News Update This year the Lupus Research Alliance Breaking Through Gala will take place the evening of Monday, November 21, 2022...
NY Jets Kickoff Luncheon Raises Funds for LRA and Honors Kenneth Farber News Update September 7, 2022 The New York Jets 2022 football season kicked off last week with a spectacular luncheon that raised...
NIH Awards $500,000 to Advance to Advance Diversity in Lupus Trials News Update August 31, 2022 We are excited to share good news – our Lupus Clinical Investigators Network, LuCIN, managed by LRA’s...
LRA Earns High Recommendations from Five Groups Evaluating U.S. Charities News Update September 1, 2022 September 5 is designated by the United Nations as the International Day of Charity – created to...
Long-time Supporter LADA Donates $150,000 to LRA-Funded Research News Update August 29, 2022 Big thanks go to the Lupus and Allied Diseases Association, Inc. (LADA) for their donation of $150,000...
Lupus Research Alliance Awards $9 Million to Develop Lupus Treatment Breakthroughs Press Release NEW YORK, NY – August 24, 2022 – The Lupus Research Alliance (LRA) today announced its Global Team Science...
New England Journal of Medicine Publishes Positive Data of Litifilimab in Cutaneous Lupus Erythematosus News Update August, 2022 We are pleased to share positive results from the two-part Phase 2 LILAC study published in the New England...
Lupus Research Alliance designa a Albert Roy como presidente y director ejecutivo Press Release August 10, 2022 NUEVA YORK, NY. 10 de agosto de 2022. Lupus Research Alliance (LRA) se complace en anunciar el nombramiento de...